MedTrace Logo

Effects of Creatine and Resistance Exercise Training in People With HIV Infection

NCT00484627 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2007-06-11

No results posted yet for this study

Summary

This study was designed determine whether use of creatine monohydrate, a dietary supplement, can increase skeletal muscle mass and strength and improve the response to progressive resistance exercise training in people with HIV infection.

Conditions

  • HIV Infections

Interventions

PROCEDURE

Use of creatine monohydrate (a dietary supplement)

BEHAVIORAL

Progressive resistance exercise training

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • Morris Schambelan, MD · University of California, San Francisco; San Francisco General Hospital

  • Kathleen Mulligan, PhD · University of California, San Francisco; San Francisco General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Completion
2003-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00484627 on ClinicalTrials.gov